| Literature DB >> 35407264 |
Giulia Siciliano1, Anna Grazia Monteduro1, Antonio Turco2, Elisabetta Primiceri2, Silvia Rizzato1, Nicoletta Depalo3, Maria Lucia Curri3,4, Giuseppe Maruccio1.
Abstract
Magnetic iron oxide nanoparticles have been extensively investigated due to their applications in various fields such as biomedicine, sensing, and environmental remediation. However, they need to be coated with a suitable material in order to make them biocompatible and to add new functionalities on their surface. This review is intended to give a comprehensive overview of recent advantages and applications of iron oxide nanoparticles coated by polydopamine film. The synthesis method of magnetic nanoparticles, their functionalization with bioinspired materials and (in particular) with polydopamine are discussed. Finally, some interesting applications of polydopamine-coated magnetic iron oxide nanoparticles will be pointed out.Entities:
Keywords: bioinspired nanomaterials; iron oxide nanoparticles; magnetic nanoparticles; polydopamine; surface functionalization
Year: 2022 PMID: 35407264 PMCID: PMC9000600 DOI: 10.3390/nano12071145
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Distinct structures of magnetic bionanocomposites: (A) core-shell Fe3O4 polydopamine nanoparticles (Fe3O4@PDA NPs) (reproduced with permission from ref. [45]. Copyright 2017 Elsevier); (B) Polydopamine@upconversion nanoparticle@mesoporous silica yolk-shell nanoparticles (PDA@UCNP@mSiO2 NPs) (reproduced with permission from ref. [46]. Copyright 2020 Elsevier); (C) Mosaic Fe3O4 polydopamine nanoparticles; (D) Au speckled SPION@SiO2 NPs (reproduced with permission from ref. [33]. Copyright 2020 John Wiley and Sons); (E) Polyethylene glycol (PEG) stabilized MnFe2O4@MnO Janus nanoparticles (reproduced with permission from ref. [48]. Copyright 2003 Royal Society of Chemistry); (F) Polymer-stabilized ferromagnetic γ-Fe2O3 dumbell nanoparticles (reproduced with permission from ref. [49]. Copyright 2013 ACS Publications).
Figure 2Number of publications with keywords: nanoparticles in combination with ■ sensing, ● biomedicine or nanomedicine or drug delivery, and ▲ bioremediation or remediation in the last years.
Figure 3The structure of Fe3O4/PDA and its interaction with metal ions. Influence on adsorption of (a) pH and ionic strength; (b) concentration; (c) Langmuir model for Cd(II) adsorption, where Qe (mg/g) is the equilibrium adsorption capacity and Ce is the Cd(II) concentration at the equilibrium conditions. Reproduced with permission from ref. [74]. Copyright 2019 Elsevier.
Fe3O4@PDA nanocomposites for the uptake of organic and inorganic pollutants.
| Biosorbent | Pollutants | Adsorption Capacity (mg/g) | pH | Reference |
|---|---|---|---|---|
| PDA-coated graphene oxide/Fe3O4 imprinted nanoparticles | Sulfonylurea | 3.176 | - | [ |
| Sodium alginate@CoFe2O4-PDA beads | Malachite green | 248.8 | ||
| Crystal violet | 456.5 | 4 | [ | |
| PDA-coated graphene oxide/Fe3O4 imprinted nanoparticles | fluoroquinolone antibiotics | 70.90 | 8 | [ |
| Fe3O4@PDA@TiO2 nanoparticles | U(VI) | 87.74 | 8.2 | [ |
| Fe3O4@PDA microspheres | Cd(II) | 296.4 | 6 | [ |
Figure 4(A) Relative viabilities of A549 cells treated with Fe3O4, PDA, and Fe3O4@PDA at a concentration of 50 μg mL−1 without or with NIR laser irradiation; (B) Photograph of tumors after excision from PBS, Fe3O4, PDA, and Fe3O4@PDA under NIR irradiation (reproduced with permission from ref. [88]. Copyright 2015 ACS Publications); (C) T1-Weighted MR imaging of xenograft 4T1 tumors in mice before and at different time points post intravenous injection of ultrasmall iron oxide nanoparticles (USIONPs); (D) MR signal/noise (S/N) ratios of tumors at different time points (reproduced with permission from ref. [28]. Copyright 2013 Royal Society of Chemistry); (E) Simultaneous detection of multiple mRNAs in living cells (reproduced with permission from ref. [39]. Copyright 2014 ACS Publications).
Fe3O4@PDA nanocomposites for biomedical applications.
| Bionanocomposite | Application | Reference |
|---|---|---|
| Core-shell Fe3O4 polydopamine nanoparticles | pH responsive drug delivery | [ |
| Core-shell Fe3O4 polydopamine nanoparticles | Intracellular mRNA detection | [ |
| Nanoclusters@PDA-PEG@ICG | Cancer therapy | [ |
| Polydopamine-coated magnetic mesoporous silica nanoparticles | Multimode cancer theranostic | [ |
| IONPs@PDA | Drug delivery system for cancer therapy | [ |
| Polydopamine (PDA)-coated magnetite nanoparticles (NPs) and spheres (sMAG) with PAMAM dendrimers | Hepatocellular carcinoma treatment | [ |
| PDA-coated iron oxide nanorods | Drug delivery system for cancer therapy | [ |
| Porous Fe3O4@PDA-PEG nanocomposite | Magnetic resonance (MR) imaging | [ |
Figure 5(A) Capture and detection of the target Pb(II) in sample solution; (B) Differential pulse voltammograms of the developed nanocomposites (reproduced with permission from ref. [101]); (C) Schematic illustration of the fabrication process of Fe3O4NPs MMIPs; (D) Cyclic voltammetry from Fe3O4NPs MMIPs-modified glassy carbon electrode (GCE) dose dependent (reproduced with permission from ref. [102]. Copyright 2017 Elsevier).
Fe3O4@PDA nanocomposites for sensing applications.
| Bionanocomposite | Application | Analyte | Reference |
|---|---|---|---|
| Fe3O4@PDA nanoparticles | Recognition and separation | Haemoglobin | [ |
| Core–shell glucose oxidase–Au–PDA–Fe3O4 nanoparticles | Glucose sensor | Glucose | [ |
| PDA@Fe3O4 MIP (Molecularly Imprinted Polymer) | Electrochemical biosensor | Thionine | [ |
| Fe3O4@PDA@MnO2 | Electrochemical sensor | Pb2+ | [ |
| PDA@Fe3O4 MIP | Impedance sensor | Dichlorodiphenyltrichloroethane (DDT) | [ |